in

Sorrento CEO, BioReference CEO And The Great Outdoors

To listen to this podcast episode, click on the Play button in the bar at the bottom of the screen. To listen while browsing, click on the Expand button at the bottom right to launch the player in a new browser tab/window.

As Sorrento Therapeutics gains FDA approval for phase two of their COVID-19 treatment, how should investors approach the stock? CEO Dr. Henry Ji checks in to discuss the company’s latest developments against coronavirus after today’s 20% gain. Then, BioReference Labs CEO Dr. Jon Cohen joins Cramer to talk about testing the NBA, major league soccer, and expanding testing throughout the U.S. as the pandemic continues. Plus, Cramer’s revealing 4 stocks in the outdoor space that could be worth looking at.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Leave a Reply

Jim DeMint And Rachel Bovard On The Progression Of Socialism In America

Missouri couple who flashed guns at demonstrators faces multiple counts